| Name | Title | Contact Details |
|---|
BDA Partners is the global investment banking advisor for Asia. We are a premium provider of Asia-related advice to sophisticated clients globally, with over 20 years` experience advising on cross-border M&A, capital raising, and financial restructuring. We provide global reach with our teams in New York and London, and true regional depth through our seven Asian offices in Tokyo, Seoul, Shanghai, Hong Kong, Ho Chi Minh City, Singapore and Mumbai. BDA has deep expertise in the Chemicals, Consumer & Retail, Health, Industrials, Services and Technology sectors. We work relentlessly to earn our clients` trust by delivering insightful advice and outstanding outcomes. BDA carries out its US securities business through BDA Advisors Inc, a broker-dealer registered with the US Securities and Exchange Commission (SEC) and a member of FINRA and SIPC. BDA`s UK subsidiary is authorised and regulated by the Financial Conduct Authority. In Hong Kong, Business Development Asia Ltd. is licensed and regulated by the Securities & Futures Commission (SFC) to conduct Type 1 and Type 4 regulated activities to professional investors.
Jefferson Partners is a Toronto, ON-based company in the Financial Services sector.
Trade Net Corporation is a Artesia, CA-based company in the Financial Services sector.
Parallax was founded in January 1999 to make control equity investments in lower middle market software and related technology companies. Parallax invests in companies with revenues between $5 and $100 million where there are creative opportunities to significantly enhance a company`s value. We welcome complex transactions or turnarounds including leveraged buy-outs, recapitalizations, corporate divestitures, spin-offs and build-ups. By seeking companies that are undergoing significant change or transition, Parallax distinguishes itself from other buyers who are unable or unwilling to provide a hands-on-approach as many of these opportunities so often require. We actively pursue investments in the USA, Canada, “Developed” Europe and Asia-Pacific. Since 1999, Parallax has participated in over 25 transactions representing over $250 million in transaction value worldwide. Our previous and current portfolio companies generate over $1 billion of annual revenues and have provided significant returns for our investors, partners and employees. Parallax has built an exceptional track record of transitioning divisions, subsidiaries and product lines into successful stand-alone entities or integrating them into current portfolio companies. Unique from other financial buyers, Parallax will take an active management role in its portfolio companies – assuming a number of interim positions within a company as required. Additionally, Parallax is further supported by an in-house staff of M&A professionals, accountants, HR specialists, and technical personnel. By leveraging this unique blend of financial capabilities and operational execution, Parallax is able to solve the array of issues associated with the sale and transition of a business.
Omega Funds is a leading international investment firm that creates and invests in life sciences companies that target the world`s most urgent medical needs. Ω is the last letter of the Greek alphabet. Our investment process starts by focusing on the end goal – delivering impactful medicines to patients. We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine and others. Early seed or late stage public financing. Large markets or rare diseases. Established targets or novel technologies. We are guided by our conviction in people, products and breakthrough ideas, not by conventional categories. Our investments span a variety of instruments from early venture rounds, to late-stage investing, direct secondary transactions, as well as company founding and creation. Omega Funds has raised more than $1 billion since its inception in 2004 and is headquartered in Boston, Massachusetts, USA.